Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults
ClinicalTrials.gov study NCT01753193. IPD Sharing: YES. Countries: 13. Publications: 1.
Open-Label Placebos to Treat Fatigue in Multiple Sclerosis
ClinicalTrials.gov study NCT04002102. IPD Sharing: YES. Countries: 1. Publications: 1.
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen
ClinicalTrials.gov study NCT01856257. IPD Sharing: YES. Countries: 1. Publications: 1.
An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
ClinicalTrials.gov study NCT00337285. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
ClinicalTrials.gov study NCT02178592. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma
ClinicalTrials.gov study NCT00866047. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
ClinicalTrials.gov study NCT00307684. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder
ClinicalTrials.gov study NCT01338818. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease
ClinicalTrials.gov study NCT02023866. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
ClinicalTrials.gov study NCT02135692. IPD Sharing: YES. Countries: 18. Publications: 1.
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
ClinicalTrials.gov study NCT02003144. IPD Sharing: Not stated. Countries: 20. Publications: 3.
Efficacy of Open Label Placebo in Children With FGIDs
ClinicalTrials.gov study NCT02389998. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)
ClinicalTrials.gov study NCT00538915. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis
ClinicalTrials.gov study NCT02061540. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Open-Label Phase 3 Long-Term Safety Study of Migalastat
ClinicalTrials.gov study NCT01458119. IPD Sharing: Not stated. Countries: 13. Publications: 1.
An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study
ClinicalTrials.gov study NCT00198029. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-Label Study of Setmelanotide in Hypothalamic Obesity
ClinicalTrials.gov study NCT04725240. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness
ClinicalTrials.gov study NCT05381454. IPD Sharing: NO. Countries: 1. Publications: 1.
Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout
ClinicalTrials.gov study NCT01356498. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
ClinicalTrials.gov study NCT01723904. IPD Sharing: Not stated. Countries: 5. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.